IPO 4168

About the Company

We are an Indian pharmaceutical and derma cosmetics company with a select portfolio of products across aesthetic dermatology, hair care, cardio diabetic and general therapeutics, offering solutions for a wide range of skin, hair, cardiovascular, diabetic and anti-aging concerns. Our products comprise pharmaceutical products, including drugs requiring prescriptions from healthcare professionals, as well as derma cosmetic products and other over-thecounter solutions for healthcare and aesthetic use. India’s aesthetic dermatology market has become one of the fastest-expanding sectors in healthcare and beauty. Valued at USD 620 million in CY25, it is projected to reach USD 1,274 Million by CY31, driven by increasing awareness of skin health, societal shifts, and the growing popularity of minimally invasive treatments. Once considered a niche, aesthetic dermatology is now widely accepted across diverse demographics, including millennials and men.